Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
New Leaf Biopharma Opportunities II, L.P. Insider Profile
4 Followers
New Leaf Biopharma Opportunities II, L.P., Director, Ten Percent Owner at Harpoon Therapeutics, holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP).
New Leaf Biopharma Opportunities II, L.P. Harpoon Therapeutics (HARP)Director, Ten Percent Owner
Harpoon Therapeutics (HARP)
Director, Ten Percent Owner
Not Ranked
New Leaf Biopharma Opportunities II, L.P. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
New Leaf Biopharma Opportunities II, L.P. does not currently own shares as a corporate insider.
A breakdown of New Leaf Biopharma Opportunities II, L.P.'s holdings
Insider Roles
Director, Ten Percent Owner
Roles that New Leaf Biopharma Opportunities II, L.P. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by New Leaf Biopharma Opportunities II, L.P.
New Leaf Biopharma Opportunities II, L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see New Leaf Biopharma Opportunities II, L.P.'s performance on stock
You May Also Like
New Leaf Biopharma Opportunities II, L.P. insider profile FAQ
What is the percentage of profitable transactions made by New Leaf Biopharma Opportunities II, L.P.?
The percentage of profitable transactions made by New Leaf Biopharma Opportunities II, L.P. is ―.
What is the average return per transaction made by New Leaf Biopharma Opportunities II, L.P.?
The average return per transaction made by New Leaf Biopharma Opportunities II, L.P. is ―.
What stocks does New Leaf Biopharma Opportunities II, L.P. hold?
New Leaf Biopharma Opportunities II, L.P. holds: HARP stocks.
What was New Leaf Biopharma Opportunities II, L.P.’s latest transaction?
New Leaf Biopharma Opportunities II, L.P. latest transaction was an Uninformative Sell of ―.
What was New Leaf Biopharma Opportunities II, L.P.'s most profitable transaction?
New Leaf Biopharma Opportunities II, L.P.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is New Leaf Biopharma Opportunities II, L.P.'s role in Harpoon Therapeutics?
New Leaf Biopharma Opportunities II, L.P.'s role in Harpoon Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.